{
    "clinical_study": {
        "@rank": "60390", 
        "arm_group": [
            {
                "arm_group_label": "Arm I (humorous followed by non-humorous movies)", 
                "arm_group_type": "Experimental", 
                "description": "Participants are provided headphones and a tablet and choose among a selection of humorous movies. Upon the third course of chemotherapy, participants are provided a selection of non-humorous movies."
            }, 
            {
                "arm_group_label": "Arm II (non-humorous followed by humorous movies)", 
                "arm_group_type": "Experimental", 
                "description": "Participants are provided headphones and a tablet and choose among a selection of non-humorous movies. Upon the third course of chemotherapy, participants are provided a selection of humorous movies."
            }
        ], 
        "brief_summary": {
            "textblock": "This randomized clinical trial studies media diversion in improving quality of life in\n      patients with recurrent gynecologic cancers receiving chemotherapy. Media diversion may\n      improve mood and quality of life in patients having cancer treatment."
        }, 
        "brief_title": "Media Diversion in Improving Quality of Life in Patients With Recurrent Gynecologic Cancers Receiving Chemotherapy", 
        "condition": "Female Reproductive Cancer", 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. To analyze the impact of a media-based intervention on patient mood during the receipt of\n      chemotherapy for recurrent gynecologic cancers.\n\n      OUTLINE: are randomized to 1 of 2 arms.\n\n      ARM I: Participants are provided headphones and a tablet and choose among a selection of\n      humorous movies. Upon the third course of chemotherapy, participants are provided a\n      selection of non-humorous movies.\n\n      ARM II: Participants are provided headphones and a tablet and choose among a selection of\n      non-humorous movies. Upon the third course of chemotherapy, participants are provided a\n      selection of humorous movies."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects with pathologically-proven gynecologic malignancies\n\n          -  Subjects who have previously completed primary treatment for a gynecologic malignancy\n\n          -  Patients receiving chemotherapy for a recurrent gynecologic cancer at the University\n             of Wisconsin-Madison Carbone Cancer Center (UWCCC)\n\n          -  Patients must be English speaking\n\n          -  Patients must have the ability to use audio media and read and understand written\n             English\n\n        Exclusion Criteria:\n\n          -  Patients unable to use audio or video media due to auditory or ocular dysfunction\n\n          -  Patients unable to read written English\n\n          -  Patients who are prisoners or incarcerated"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "66", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01901835", 
            "org_study_id": "UW13037", 
            "secondary_id": [
                "NCI-2013-01284", 
                "2013-0618", 
                "P30CA014520"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Arm I (humorous followed by non-humorous movies)", 
                    "Arm II (non-humorous followed by humorous movies)"
                ], 
                "description": "Participate in media diversion with humorous and non-humorous movies", 
                "intervention_name": "mind-body intervention procedure", 
                "intervention_type": "Procedure", 
                "other_name": "mind-body interventions"
            }, 
            {
                "arm_group_label": [
                    "Arm I (humorous followed by non-humorous movies)", 
                    "Arm II (non-humorous followed by humorous movies)"
                ], 
                "description": "Ancillary studies", 
                "intervention_name": "survey administration", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Arm I (humorous followed by non-humorous movies)", 
                    "Arm II (non-humorous followed by humorous movies)"
                ], 
                "description": "Ancillary studies", 
                "intervention_name": "quality-of-life assessment", 
                "intervention_type": "Procedure", 
                "other_name": "quality of life assessment"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 12, 2014", 
        "location": {
            "contact": {
                "email": "cancerconnect@uwcarbone.wisc.edu", 
                "last_name": "Stephen L. Rose", 
                "phone": "800-622-8922"
            }, 
            "facility": {
                "address": {
                    "city": "Madison", 
                    "country": "United States", 
                    "state": "Wisconsin", 
                    "zip": "53792"
                }, 
                "name": "University of Wisconsin Hospital and Clinics"
            }, 
            "investigator": {
                "last_name": "Stephen L. Rose", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effects of a Media Diversion on Quality of Life in Patients Receiving Chemotherapy for Recurrent Gynecologic Cancers", 
        "overall_official": {
            "affiliation": "University of Wisconsin Hospital and Clinics", 
            "last_name": "Stephen Rose", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Summarized in terms of means, standard deviations and ranges, stratified by group and assessment time point. Absolute and percentage changes from baseline within each group will be calculated and reported in terms of means and the corresponding 95% confidence intervals. Changes from baseline will be evaluated using a paired t-test. A Grizzle model for a 2 X 2 cross-over design will be used to compare changes in PANAS-X positive and negative affect scores between groups.", 
            "measure": "Patient-reported mood using the Positive and Negative Affect Scale-Expanded Form (PANAS-X) instrument", 
            "safety_issue": "No", 
            "time_frame": "Up to day 1 of course 3 of chemotherapy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01901835"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Summarized in terms of means, standard deviations and ranges, stratified by group and assessment time point. Absolute and percentage changes from baseline within each group will be calculated and reported in terms of means and the corresponding 95% confidence intervals. Changes from baseline will be evaluated using a paired t-test. A Grizzle model for a 2 X 2 cross-over design will be used to compare changes in HSQ total scores between groups.", 
                "measure": "Humor Styles Questionnaire (HSQ) total score", 
                "safety_issue": "No", 
                "time_frame": "Up to day 1 of course 3 of chemotherapy"
            }, 
            {
                "description": "Summarized in terms of means, standard deviations and ranges, stratified by group and assessment time point. Absolute and percentage changes from baseline within each group will be calculated and reported in terms of means and the corresponding 95% confidence intervals. Changes from baseline will be evaluated using a paired t-test. A Grizzle model for a 2 X 2 cross-over design will be used to compare changes in BFI total scores between groups.", 
                "measure": "Brief Fatigue Inventory (BFI) total score", 
                "safety_issue": "No", 
                "time_frame": "Up to day 1 of course 3 of chemotherapy"
            }, 
            {
                "description": "Assessed with a Likert scale at the completion of the subject's participation to understand how the intervention may be improved should results of this study favor implementation into standard clinical procedure for future patients. Summarized in terms of medians and ranges, stratified by group and assessment time point. Changes from baseline within each group will be evaluated using a nonparametric Wilcoxon Signed Rank test", 
                "measure": "Ease of use (EoS) score", 
                "safety_issue": "No", 
                "time_frame": "Up to day 1 of course 3 of chemotherapy"
            }, 
            {
                "description": "Assessed with a Likert scale at the completion of the subject's participation to understand how the intervention may be improved should results of this study favor implementation into standard clinical procedure for future patients. Summarized in terms of medians and ranges, stratified by group and assessment time point. Changes from baseline within each group will be evaluated using a nonparametric Wilcoxon Signed Rank test", 
                "measure": "Quality of materials (QOM) score", 
                "safety_issue": "No", 
                "time_frame": "Up to day 1 of course 3 of chemotherapy"
            }
        ], 
        "source": "University of Wisconsin, Madison", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Wisconsin, Madison", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}